| Primary |
| Gastrooesophageal Reflux Disease |
49.4% |
| Hypertension |
6.1% |
| Dyspepsia |
5.6% |
| Pain |
5.0% |
| Depression |
3.7% |
| Hiatus Hernia |
3.1% |
| Anxiety |
2.5% |
| Gastritis |
2.5% |
| Blood Pressure Abnormal |
2.3% |
| Diabetes Mellitus |
2.2% |
| Sleep Disorder |
2.1% |
| Barrett's Oesophagus |
2.1% |
| Cardiac Disorder |
2.1% |
| Ulcer |
1.8% |
| Bipolar Disorder |
1.8% |
| Blood Cholesterol Increased |
1.7% |
| Blood Cholesterol Abnormal |
1.7% |
| Gastric Disorder |
1.6% |
| Gastric Ulcer |
1.4% |
| Asthma |
1.4% |
|
| Drug Dose Omission |
21.1% |
| Gastrooesophageal Reflux Disease |
9.8% |
| Malaise |
8.2% |
| Osteoporosis |
7.6% |
| Vomiting |
6.7% |
| Multiple Fractures |
5.0% |
| Drug Ineffective |
4.9% |
| Intentional Drug Misuse |
4.8% |
| Dyspepsia |
4.8% |
| Off Label Use |
3.9% |
| Pain |
3.9% |
| Weight Decreased |
2.6% |
| Myocardial Infarction |
2.3% |
| Nausea |
2.2% |
| Throat Irritation |
2.2% |
| Abdominal Pain Upper |
2.2% |
| Gastric Disorder |
2.1% |
| Death |
2.0% |
| Neoplasm Malignant |
2.0% |
| Cerebrovascular Accident |
1.9% |
|
| Secondary |
| Gastrooesophageal Reflux Disease |
38.2% |
| Dyspepsia |
8.3% |
| Hypertension |
6.0% |
| Pain |
5.8% |
| Hiatus Hernia |
4.7% |
| Depression |
4.4% |
| Product Used For Unknown Indication |
3.3% |
| Drug Use For Unknown Indication |
3.1% |
| Cardiac Disorder |
2.7% |
| Sleep Disorder |
2.4% |
| Anxiety |
2.4% |
| Gastritis |
2.4% |
| Ulcer |
2.3% |
| Gastric Disorder |
2.2% |
| Asthma |
2.1% |
| Blood Pressure |
2.0% |
| Osteoporosis |
2.0% |
| Abdominal Discomfort |
2.0% |
| Barrett's Oesophagus |
1.9% |
| Blood Pressure Abnormal |
1.7% |
|
| Off Label Use |
11.6% |
| Vomiting |
9.0% |
| Weight Decreased |
8.2% |
| Vitamin D Deficiency |
8.0% |
| Intentional Drug Misuse |
6.4% |
| Drug Ineffective |
5.9% |
| Malaise |
5.9% |
| Drug Dose Omission |
5.6% |
| Weight Increased |
5.2% |
| Osteoporosis |
5.2% |
| Gastrooesophageal Reflux Disease |
4.3% |
| Wrist Fracture |
4.2% |
| Pain |
3.7% |
| Nausea |
2.7% |
| Throat Irritation |
2.6% |
| Pain In Extremity |
2.6% |
| Dyspepsia |
2.5% |
| Upper Limb Fracture |
2.4% |
| Thrombocytopenia |
2.1% |
| Pneumonia |
1.8% |
|
| Concomitant |
| Product Used For Unknown Indication |
27.0% |
| Drug Use For Unknown Indication |
18.0% |
| Hypertension |
7.1% |
| Gastrooesophageal Reflux Disease |
6.0% |
| Pain |
5.4% |
| Rheumatoid Arthritis |
5.0% |
| Depression |
4.2% |
| Osteoporosis |
2.7% |
| Asthma |
2.7% |
| Crohn's Disease |
2.7% |
| Prophylaxis |
2.6% |
| Diabetes Mellitus |
2.5% |
| Anxiety |
2.3% |
| Blood Cholesterol Increased |
2.3% |
| Multiple Myeloma |
2.0% |
| Chronic Obstructive Pulmonary Disease |
1.7% |
| Insomnia |
1.5% |
| Osteoarthritis |
1.4% |
| Nausea |
1.4% |
| Type 2 Diabetes Mellitus |
1.4% |
|
| Vomiting |
14.5% |
| Weight Decreased |
11.8% |
| Weight Increased |
7.8% |
| Nausea |
6.9% |
| Pain |
5.8% |
| Drug Ineffective |
4.6% |
| Death |
4.3% |
| Pneumonia |
4.0% |
| Pyrexia |
3.9% |
| Urinary Tract Infection |
3.9% |
| Vision Blurred |
3.6% |
| Tremor |
3.5% |
| Myocardial Infarction |
3.4% |
| Rash |
3.3% |
| Pulmonary Embolism |
3.3% |
| Dyspnoea |
3.3% |
| Pain In Extremity |
3.1% |
| Somnolence |
3.1% |
| Thrombocytopenia |
3.0% |
| Headache |
2.9% |
|
| Interacting |
| Product Used For Unknown Indication |
36.0% |
| Drug Use For Unknown Indication |
9.7% |
| Gastrooesophageal Reflux Disease |
9.3% |
| Depression |
5.5% |
| Pain |
5.1% |
| Gastritis |
4.1% |
| Hiatus Hernia |
3.7% |
| Trigeminal Neuralgia |
3.1% |
| Atrial Fibrillation |
2.8% |
| Hypertension |
2.5% |
| Myocardial Infarction |
2.5% |
| Gastric Ulcer |
2.0% |
| Blood Cholesterol Increased |
1.9% |
| Essential Hypertension |
1.9% |
| Ulcer |
1.9% |
| Dyspnoea |
1.7% |
| Abdominal Discomfort |
1.6% |
| Anaesthesia |
1.6% |
| Anxiety |
1.5% |
| Osteoporosis |
1.4% |
|
| Drug Interaction |
24.3% |
| Petechiae |
8.3% |
| Weight Decreased |
8.3% |
| Inappropriate Schedule Of Drug Administration |
7.6% |
| Vomiting |
7.6% |
| Tremor |
5.6% |
| Abdominal Discomfort |
4.2% |
| Myalgia |
4.2% |
| International Normalised Ratio Increased |
3.5% |
| Sedation |
3.5% |
| Somnolence |
3.5% |
| Tongue Haematoma |
3.5% |
| Fatigue |
2.8% |
| Myopathy |
2.8% |
| Hypothyroidism |
2.1% |
| Overdose |
2.1% |
| Pain In Extremity |
2.1% |
| Abdominal Pain |
1.4% |
| Blood Triglycerides Increased |
1.4% |
| Cerebrovascular Accident |
1.4% |
|
